Tag:
VenatoRx
Latest Headlines
Latest Headlines
Novartis shuts down Protez, shelves $400M antibiotic program
When Novartis trumpeted its $400 million deal to buy Malvern, PA-based Protez Pharmaceuticals back in 2008, the pharma giant spotlighted the small biotech's promising antibiotic PZ-601. Today,
